St. Louis, Missouri – November 30, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to Massachusetts General Hospital (MGH).

Researchers at MGH will use Partek to detect copy number variation in family research. MHG, the third oldest hospital in the United States, is dedicated to research that improves the lives of their patients. MHG is located in Boston.

St. Louis, Missouri – November 30, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to the Novartis Institutes for Biomedical Research (NIBR).

Researchers at NIBR will use Partek GS to analyze genomic data. NIBR, Novartis’ research organization, is dedicated to finding new treatments for areas within dermatology, oncology, and immunology. Headquartered in Cambridge, Massachusetts, NIBR has sites all over the world including in Basel, Switzerland; Vienna, Austria; Horsham, UK; Tsukuba, Japan, Shanghai, China; and East Hanover, New Jersey.

St. Louis, Missouri – November 30, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to Heart Research Institute (HRI).

Scientists at HRI will use Partek to analyze gene expression data generated from studies about the effects of sex hormones in heart disease and the link between diabetic kidney disease and heart disease. HRI is Australia’s leading institute for atherosclerosis research and was founded in 1989. HRI is located in New South Wales.

St. Louis, Missouri – November 26, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to the French National Institute for Health and Medical Research (INSERM) and the University of Nantes.

Researchers at INSERM and the University of Nantes will use Partek GS to analyze data from expression and genotyping studies on tumor cells. The INSERM, established in 1964, is a public scientific organization that is dedicated to promoting health and well being of all citizens. The University of Nantes is located in Nantes, France.

St. Louis, Missouri – November 20, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to Kuwait University (KU).

The Health Sciences Center at KU will use Partek GS for a variety of applications. Kuwait University, located in Kuwait City. Partek GS allows for thorough analysis of gene expression, exon alternative splicing, copy number, genome-wide SNP, and ChIP-chip regulation data within in the same software package. In addition, Partek GS provides easy to use workflows to walk through the analysis process. Partek GS is Affymetrix GeneChip-compatible^TM for gene expression analysis, exon expression analysis, chromosomal copy number analysis, tiling array analysis, and chromosomal copy number analysis of high density SNP arrays.

St. Louis, Missouri – November 14, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to Erasmus Medical Center (Erasmus MC).

Erasmus MC has recently expanded the number of Partek licenses in use at the facility. Located in Rotterdam, The Netherlands, Erasmus MC is a first class research hospital that also includes the Erasmus MC – Sophia hospital for children and the Erasmus MC – Daniel den Hoed Cancer Center.

St. Louis, Missouri – November 13, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to Roche Molecular Diagnostics (Roche).

Researchers at Roche Molecular Diagnostics will use Partek GS to analyze diagnostic data from a variety of studies involving drug development. Current research at Roche involves using biomarkers to determine patients’ reactions to specific medications, as well as drug discovery. Roche, a leader in the pharmaceutical industry, has provided such therapeutic drugs as Tamiflu^®, Herceptin^®, and Boniva^®.

St. Louis, Missouri – November 12, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to the University of Maryland.

Partek GS will be used throughout the campus of the University of Maryland. Researchers at the School of Medicine will use Partek GS to analyze data from current studies on genetic variation in schizophrenia. In another area of campus, researchers at the School of Nursing are using Partek GS to analyze data from research on chronic pain. The University of Maryland is located in College Park.

St. Louis, Missouri – November 12, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to the Korean National Genome Research Institute.

Researchers at the Institute will analyze genomic data with Partek GS. The Institute is part of the Korea National Institute of Health. Partek GS software provides powerful statistical analysis integrated with interactive data visualization and is designed to efficiently process large volumes of high-dimensional genomic/proteomic data.

St. Louis, Missouri – November 12, 2007 – Partek Incorporated announced today that Cardiff University has renewed their license agreement for Partek^® Genomics Suite^TM (Partek GS) software.

Cardiff University, located in Wales, was founded in 1883. Partek GS allows for thorough analysis of gene expression, exon alternative splicing, copy number, genome-wide SNP, and ChIP-chip regulation data within in the same software package. In addition, Partek GS provides easy to use workflows to walk through the analysis process. Partek GS is Affymetrix GeneChip-compatible^TM for gene expression analysis, exon expression analysis, chromosomal copy number analysis, tiling array analysis, and chromosomal copy number analysis of high density SNP arrays.